![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/04/21/2652134/0/en/Vallon-Pharmaceuticals-Completes-Merger-with-GRI-Bio-Inc.html
https://www.globenewswire.com/news-release/2023/04/20/2651660/0/en/Vallon-Pharmaceuticals-Announces-Stockholder-Approval-of-Merger-with-GRI-Bio-Inc-and-Reverse-Stock-Split.html
https://www.globenewswire.com/news-release/2023/04/12/2645721/0/en/Vallon-Pharmaceuticals-Adjourns-Special-Meeting-of-Stockholders-Until-April-20-2023.html
https://www.globenewswire.com/news-release/2023/04/04/2640773/0/en/Vallon-Pharmaceuticals-Provides-an-Update-on-Proxy-Voting-for-the-Proposed-Merger-with-GRI-Bio-and-Urges-Stockholders-of-Record-as-of-March-6-2023-to-Vote-by-April-11-2023-at-11-59.html
https://www.globenewswire.com/news-release/2023/02/24/2615171/0/en/Vallon-Pharmaceuticals-Reports-Fiscal-Year-2022-Financial-Results.html
https://www.globenewswire.com/news-release/2023/01/11/2587096/0/en/Vallon-Pharmaceuticals-and-GRI-Bio-to-Present-at-the-Virtual-Investor-2023-Companies-to-Watch-Event.html
https://www.globenewswire.com/news-release/2022/12/13/2573220/0/en/Vallon-Pharmaceuticals-and-GRI-Bio-Enter-into-Merger-Agreement-with-Goal-of-Advancing-Innovative-Pipeline-of-NKT-Cell-Regulators.html
https://www.globenewswire.com/news-release/2022/11/03/2548370/0/en/Vallon-Pharmaceuticals-Reports-Third-Quarter-2022-Financial-Results.html
https://www.globenewswire.com/news-release/2022/07/28/2487785/0/en/Vallon-Pharmaceuticals-Reports-Second-Quarter-2022-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2022/05/13/2443029/0/en/Vallon-Pharmaceuticals-Announces-3-9-Million-Registered-Direct-Offering.html